Suzhou Basecare Medical Corporation Limited (2170.HK)
2170.HK Stock Price Chart
Explore Suzhou Basecare Medical Corporation Limited interactive price chart. Choose custom timeframes to analyze 2170.HK price movements and trends.
2170.HK Company Profile
Discover essential business fundamentals and corporate details for Suzhou Basecare Medical Corporation Limited (2170.HK) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
8 Feb 2021
Employees
497.00
Website
https://www.basecare.cnCEO
Bo Liang
Description
Suzhou Basecare Medical Corporation Limited, an investment holding company, engages in the research, development, manufacture, and provision of genetic testing solutions for assisted reproduction and sale of genetic testing devices and instruments in the People's Republic of China. The company offers genetic test kit products, which include pre-implantation genetic test kits, such as PGT-A to detect aneuploidy; PGT-M to detect single-gene or monogenic defects in pre-implantation embryos; and PGT-SR kits to detect chromosome structural rearrangements, which are common causes of recurrent miscarriage. It also provides prenatal test kit products comprising CNV kits; postnatal test kit products consist of WES kits; and devices and instruments, including liquid nitrogen storage dewar, cryostorage system, automated workstation, sperm quality analyzer, and NGS sequencer. The company also engages in the research, development, manufacture, and sale of medical devices and instruments. In addition, it provides marketing services; and engages in the research and development of software for medical devices and instruments. The company serves hospitals and reproductive clinics. Suzhou Basecare Medical Corporation Limited was incorporated in 2010 and is headquartered in Suzhou, China.
2170.HK Financial Timeline
Browse a chronological timeline of Suzhou Basecare Medical Corporation Limited corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 6 Jun 2025
Earnings released on 6 Jun 2025
Earnings released on 28 Mar 2025
EPS came in at -$0.24 , while revenue for the quarter reached $96.48M .
Earnings released on 31 Dec 2024
EPS came in at -$0.23 , while revenue for the quarter reached $92.75M .
Earnings released on 29 Aug 2024
EPS came in at -$0.24 , while revenue for the quarter reached $66.98M .
Earnings released on 6 Jun 2024
EPS came in at -$0.24 , while revenue for the quarter reached $67.48M .
Earnings released on 28 Mar 2024
EPS came in at -$0.52 , while revenue for the quarter reached $132.57M , missing expectations by -66.61%.
Earnings released on 2 Mar 2024
EPS came in at -$0.26 , while revenue for the quarter reached $65.66M .
Earnings released on 31 Aug 2023
EPS came in at -$0.25 , while revenue for the quarter reached $96.67M .
Earnings released on 31 Mar 2023
EPS came in at -$0.13 , while revenue for the quarter reached $48.82M .
Earnings released on 30 Mar 2023
EPS came in at -$0.40 , while revenue for the quarter reached $81.17M , missing expectations by -72.96%.
Earnings released on 30 Mar 2023
Earnings released on 29 Aug 2022
EPS came in at -$0.15 , while revenue for the quarter reached $82.72M .
Earnings released on 31 Mar 2022
EPS came in at -$0.45 , while revenue for the quarter reached $69.09M .
Earnings released on 29 Mar 2022
Earnings released on 30 Aug 2021
EPS came in at -$0.18 , while revenue for the quarter reached $60.14M .
Earnings released on 31 Mar 2021
EPS came in at -$0.98 , while revenue for the quarter reached $96.33M .
Earnings released on 31 Dec 2020
EPS came in at -$0.98 , while revenue for the quarter reached $96.33M .
2170.HK Stock Performance
Access detailed 2170.HK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.